Pelihealth’s Post

March is National Endometriosis Month, and it's the perfect time to highlight the ground-breaking strides being made in clinical trials for endometriosis. This spring, Andrew Horne, Professor of Gynaecology and Reproductive Sciences at the University of Edinburgh, is moving a clinical trial of DCA in endometriosis cases into its second phase - with hopes the drug could be prescribed as a treatment on the NHS within the next five years. Clinical research is the driving force behind improved diagnostics, treatments, and, ultimately, enhanced quality of life for those affected by this complex condition. #endometriosisawareness #clinicalresearch

𝐌𝐚𝐫𝐜𝐡 𝐦𝐚𝐫𝐤𝐬 𝐄𝐧𝐝𝐨𝐦𝐞𝐭𝐫𝐢𝐨𝐬𝐢𝐬 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐌𝐨𝐧𝐭𝐡. 📣 First off, what is Endometriosis? Endometriosis is an inflammatory condition where endometrial tissue grows outside of the uterus. As you can imagine, this is incredibly painful for those suffering with the condition. 👉 There's no known cure. 👉 Treatment is often problematic. 👉 It affects 10% of Women of reproductive age. (That's 180 million globally!). 👉 AND it takes, on average, 8-10 years between the onset of the disease and its diagnosis. ⛈ But it's not all doom and gloom as there are some incredible companies in the Femtech space working to influence this area of Women's Health that I encourage anyone to check out, especially during this month! ENDODIAG - Based in France and working to develop products and services aimed at improving the diagnosis of endometriosis. DotLab - Based in the US and developing a breakthrough, non-invasive, blood test that aids in the diagnosis of active endometriosis. Hera Biotech - US Based and on a mission to commercialize the MetriDx, a novel, non-surgical method for the definitive and early diagnosis of endometriosis. @Luna - A digital healthcare platform for women with endometriosis. Helping to reduce the delayed diagnosis and strengthen medical care. Syrona Health - UK based Syrona Health is helping Women track their symptoms and provides free support for chronic gynaecological health conditions including endometriosis. SO much more needs to be done in this area of the industry. To my network, please share resources around this condition in the comments and any other innovative Femtech companies tackling Endometriosis! 💡 #endometriosis #femtech

🌟 Exciting update in the healthcare sector! NICE now recommends abaloparatide for treating osteoporosis in postmenopausal women, trans men, and non-binary individuals at high fracture risk. This new guidance aims to enhance bone health and reduce fracture risks, providing a much-needed alternative for those with limited treatment options. Learn more about the clinical and economic benefits of this recommendation. #SyenzaNews #Healthcare #Osteoporosis #ElderlyCare #NICEGuidance https://lnkd.in/e7K6UYie

AccendoWave - A Pain #Data Company Men and women experience #pain differently, and until now, scientists didn’t know why. New research says it may be in part due to differences in male and female nerve cells. Pain-sensing nerve cells from male and female animal tissues responded differently to the same sensitizing substances, researchers report June 3 in Brain. The results suggest that at the cellular level, pain is produced differently between the sexes. A Top 4 Global Health Equity Solution and Top 15 Global Remote Monitoring Company, AccendoWave, benchmarks objective brain wave pain data (specialty, gender, age) and has nine #pain databases: Emergency Department, Maternal Health, Oncology, MSK, Medical Surgical, ICU, #Women, Adults, Seniors to eliminate bias, improve outcomes and reduce health care costs. If desired, AccendoWave can also create customized pain databases for partners that can be accessed on the Datavant platform. https://lnkd.in/gS5QipQa

Peripheral Neuropathies, Awareness Rising Neuropathies concern also Diabetic patients, Did you know possible foot impacts? Follow Saxol page on linkedin ! #CIPN #diabetes #aging #neuropathies #cnrs IAB Grenoble, #Linksium, #cnrsalpes

Falls are the leading cause of iniury in adults aged 65 years or older and can result in loss of independence and decreased quality of life. Falls in oncology patients can be a significant concern due to treatment side effects such as fatigue, dizziness, neuropathy, weakness, and even osteoporosis. Here are some simple exercises that can prevent falls and improve balance. Please share with your loved ones and patients and encourage them to do it daily as tolerated. #oncologycare #fallrisk #physiotherapy

🌟 Exciting News for Women's Health! 🌟 Research by the Endocrine Society indicates that traditional care for managing polycystic ovary syndrome (PCOS) often leads to patient dissatisfaction due to the lack of trust and emotional support. Many patients report a disconnect between their needs and the care they receive, with women consulting multiple providers before receiving a diagnosis. This frustration is compounded by episodic care models that mainly focus on medications and decision pathways determined by insurance approvals, rather than addressing the broader lifestyle and metabolic challenges associated with PCOS/HRT. Digital only solutions, similar to diabetes, as a layer to the dysfunctional episodic care model, has not yielded meaningful results. GluCare.Health, has launched a Hybrid Women's Hormonal Health Program, designed to support women managing Polycystic Ovarian Syndrome (PCOS) and Perimenopause. This marks our fourth hybrid program launch after diabetes, obesity, cardiology. Here’s why our approach is different: 🔹 Our integrated team tracks and monitors these crucial metrics (including ŌURA metrics) in real time, delivering data-driven, personalized care. 🔹 Instead of focusing solely on medication, we use advanced diagnostics combined with behavioral science to empower women to regain control of their health and improving outcomes by measuring, analyzing and reporting data. All PCOS/HRT patients at GluCare.Health will receive this care as standard, with no additional costs to insurance companies or patients. We’re revolutionizing how women’s health is managed and continue in our quest to implement real changes to outdated care models. More info: https://lnkd.in/dGdBFRrw PCOS: https://lnkd.in/dXUXQNcJ Ali Hashemi Zeina A. meta[bolic] ŌURA Tom Hale #dubaihealthauthority

Riva Clinic Hormone & Spine Ortho Diagnosis and Treatment Approaches Accurate diagnosis is paramount in managing thyroid disorders effectively. Physicians employ various tests, including blood tests, imaging studies, and biopsy, to assess thyroid function and identify underlying conditions. Dr. Vaishakhi Rustagi Consultant Pediatric and Adolescent Endocrinologist Web: www.rivaclinic.com #MedicalDiagnosis #TreatmentApproaches #HealthcareSolutions #DiagnosisAndTreatment #ClinicalDiagnosis #TreatmentOptions #PatientCare #HealthDiagnosis #MedicalTreatment #DiseaseManagement

AccendoWave - A pain #Data Company Women with endometriosis who have endured years of excruciating pain are being “fobbed off” by doctors and told their symptoms are “all in their head”, leading them to give up seeking NHS treatment, new research has found. A study carried out by academics at Manchester Metropolitan University found women with the disease felt “gaslit” by doctors due to their lack of understanding of the condition. The paper, due to be published in the Journal of Health Communication later this month, also found that treatment was subject to a postcode lottery. Patients in rural areas reported travelling for hours to access a specialist with full training in the complex gynaecological condition. A Top 4 Global Health Equity Solution and Top 15 Global Remote Monitoring Company, AccendoWave, benchmarks objective brain wave pain data (specialty, gender, age) and has nine #pain databases: Emergency Department, Maternal Health, Oncology, MSK, Medical Surgical, ICU, Women, Adults, Seniors to eliminate bias, improve outcomes and reduce health care costs. If desired, AccendoWave can also create customized pain databases for partners that can be accessed on the Datavant platform. https://lnkd.in/gwEfHkcu

AccendoWave - A Pain #Data Company A Cedars-Sinai study of 18,000 #women. Let's highlight this again - a Cedars-Sinai study of 18,000 #women. The disparities were observed even among patients reporting the highest #pain levels. A Top 4 Global Health Equity Solution and Top 15 Global Remote Monitoring Company, AccendoWave, benchmarks objective brain wave pain data (specialty, gender, age) and has nine #pain databases: Emergency Department, #Maternal #Health, Oncology, MSK, Medical Surgical, ICU, #Women, Adults, Seniors to eliminate bias, improve outcomes and reduce health care costs. If desired, AccendoWave can also create customized pain databases for partners that can be accessed on the Datavant platform.